Closed
SectorHealthcare
42.85 9.51
24h
Min
42.85
Max
43.52
Income | -607M -448M |
---|---|
Sales | 86M 745M |
P/E Sector Avg | 27.205 51.198 |
EPS | -3.42 |
Profit margin | -60.08 |
Employees | 1,372 |
EBITDA | -560M -369M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +118.97% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | -6.7B 3.7B |
---|---|
Previous open | 33.34 |
Previous close | 42.85 |
By Acuity
50%
50%
166 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 94.18 USD 118.97%
High 188 USD
Low 40 USD
Based on 24 Wall Street analysts offering 12 month price targets forSarepta Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$